[Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application].

about

[Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application].

Item

http://www.wikidata.org/entity/Q49958882

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@en

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@nl

type

Item

label

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@en

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@nl

prefLabel

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@en

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@nl

P1476

[Novel Immuno-oncology Therapy ...... and Prospect of Application].

@en

P2093

Shengxiang Ren

http://www.w3.org/2001/XMLSchema#string

Shijia Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

Antibody-drug conjugates as novel anti-cancer chemotherapeutics

Trial watch: IDO inhibitors in cancer therapy

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

P304

645-651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2017.09.10

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28935020

http://www.w3.org/2001/XMLSchema#string

P932

5973373

http://www.w3.org/2001/XMLSchema#string